162 related articles for article (PubMed ID: 21092168)
1. Reasons for illicit drug use in people with schizophrenia: Qualitative study.
Asher CJ; Gask L
BMC Psychiatry; 2010 Nov; 10():94. PubMed ID: 21092168
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
3. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
[TBL] [Abstract][Full Text] [Related]
4. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.
Schaub M; Fanghaenel K; Stohler R
Aust N Z J Psychiatry; 2008 Dec; 42(12):1060-5. PubMed ID: 19016094
[TBL] [Abstract][Full Text] [Related]
5. Relationships between symptoms of schizophrenia and substance abuse.
Brunette MF; Mueser KT; Xie H; Drake RE
J Nerv Ment Dis; 1997 Jan; 185(1):13-20. PubMed ID: 9040528
[TBL] [Abstract][Full Text] [Related]
6. Reasons for substance use in schizophrenia.
Addington J; Duchak V
Acta Psychiatr Scand; 1997 Nov; 96(5):329-33. PubMed ID: 9395149
[TBL] [Abstract][Full Text] [Related]
7. Relapse in schizophrenia: is there a relationship to substance abuse?
Gupta S; Hendricks S; Kenkel AM; Bhatia SC; Haffke EA
Schizophr Res; 1996 May; 20(1-2):153-6. PubMed ID: 8794503
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
[TBL] [Abstract][Full Text] [Related]
9. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
Kirkpatrick B; Amador XF; Flaum M; Yale SA; Gorman JM; Carpenter WT; Tohen M; McGlashan T
Schizophr Res; 1996 May; 20(1-2):69-77. PubMed ID: 8794495
[TBL] [Abstract][Full Text] [Related]
10. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse.
Lammertink M; Löhrer F; Kaiser R; Hambrecht M; Pukrop R
Acta Psychiatr Scand; 2001 Nov; 104(5):361-6. PubMed ID: 11722317
[TBL] [Abstract][Full Text] [Related]
11. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia.
Joyal CC; Hallé P; Lapierre D; Hodgins S
Schizophr Res; 2003 Oct; 63(3):297-9. PubMed ID: 12957709
[No Abstract] [Full Text] [Related]
12. [Influence of resistance to voices on depression].
Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
Verdoux H; Mury M; Besançon G; Bourgeois M
Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
[TBL] [Abstract][Full Text] [Related]
14. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
Coulston CM; Perdices M; Tennant CC
Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
[TBL] [Abstract][Full Text] [Related]
15. [Schizophrenia and substance dependence].
Uchtenhagen A
Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):215-23. PubMed ID: 8658102
[TBL] [Abstract][Full Text] [Related]
16. Substance abuse and cognitive functioning in schizophrenia.
Addington J; Addington D
J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
[TBL] [Abstract][Full Text] [Related]
17. Correlates of patterns of substance abuse among patients with schizophrenia.
Cuffel BJ; Heithoff KA; Lawson W
Hosp Community Psychiatry; 1993 Mar; 44(3):247-51. PubMed ID: 8444435
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis.
Hunt GE; Large MM; Cleary M; Lai HMX; Saunders JB
Drug Alcohol Depend; 2018 Oct; 191():234-258. PubMed ID: 30153606
[TBL] [Abstract][Full Text] [Related]
19. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
20. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
